GenScript Unveils TurboCHO™ Protein Expression Kit Designed to Accelerate Antibody Development
GenScript Unveils TurboCHO™ Protein Expression Kit to Drive Antibody Development
GenScript Biotech Corporation recently launched its latest innovation, the TurboCHO™ Protein Expression Kit, at the PEGS Summit in Boston. This next-generation antibody expression reagent promises researchers across the globe the fastest pathway to high-quality antibodies, significantly boosting the speed and efficiency of drug discovery and biologics development.
The TurboCHO™ Kit is designed to set a new standard in the expression reagent market, characterized by its high throughput and AI-enabled capabilities. In a world where time is of the essence, this kit allows laboratories—regardless of size—to produce research-grade proteins in as little as five business days. By enabling quicker access to reliable data, researchers can make informed decisions earlier in their projects, ultimately accelerating the pace of scientific discovery.
A Leap Forward in Protein Expression
“TurboCHO™ Protein Expression Kit delivers outstanding performance and unmatched value, putting powerful innovation within reach of every lab working to advance science,
Topics Other）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.